1. Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
- Author
-
Moon Young Choi, Donghyun Jee, and Jin-woo Kwon
- Subjects
0301 basic medicine ,Male ,Vascular Endothelial Growth Factor A ,genetic structures ,Medical Implants ,Physiology ,Visual Acuity ,Pathology and Laboratory Medicine ,Biochemistry ,Biomarkers, Pharmacological ,Dexamethasone ,Diagnostic Radiology ,chemistry.chemical_compound ,Placental Growth Factor ,0302 clinical medicine ,Endocrinology ,Edema ,Medicine and Health Sciences ,Diabetes diagnosis and management ,Tomography ,Immune Response ,Multidisciplinary ,Radiology and Imaging ,Diabetic retinopathy ,Middle Aged ,Vascular endothelial growth factor ,Bevacizumab ,Intravitreal Injections ,Medicine ,Engineering and Technology ,Retinal Disorders ,Female ,medicine.symptom ,Tomography, Optical Coherence ,medicine.drug ,Research Article ,Biotechnology ,medicine.medical_specialty ,HbA1c ,Imaging Techniques ,Endocrine Disorders ,Science ,Immunology ,Urology ,Bioengineering ,Research and Analysis Methods ,Macular Edema ,Aqueous Humor ,Diabetes Complications ,03 medical and health sciences ,Signs and Symptoms ,Refractory ,Diagnostic Medicine ,Diabetes mellitus ,Growth Factors ,medicine ,Diabetes Mellitus ,Humans ,Hemoglobin ,Retinopathy ,Glucocorticoids ,Placenta Growth Factor ,Inflammation ,Diabetic Retinopathy ,Endocrine Physiology ,business.industry ,Interleukins ,Biology and Life Sciences ,Proteins ,Odds ratio ,medicine.disease ,eye diseases ,Ophthalmology ,030104 developmental biology ,chemistry ,Metabolic Disorders ,030221 ophthalmology & optometry ,Medical Devices and Equipment ,Implant ,business - Abstract
PurposeTo determine the characteristics of diabetic macular edema (DME) patients refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone implant.MethodsWe classified 119 DME patients according to whether or not they are responsive to 3 consecutive monthly anti-VEGF treatments and/or an additional dexamethasone implant. We compared their concentrations of IL (interleukin)-1β, IL-8, IL-10, IL-17, placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the aqueous humor as well as their optical coherence tomography (OCT) findings, and baseline characteristics. We used logistic regression analyses to identify preoperative factors related to refractoriness to treatments.ResultsOf 119 treatment-naïve DME patients, 50 (42.02%) patients showed responsiveness [central subfield thickness (CST) < 300μm] after 3 IVBs, and 59 (49.58%) patients showed responsiveness after an additional dexamethasone implant, but 10 (8.40%) patients showed CST 300 ≥ μm even after both treatments. Refractory DME patients showed significantly higher number of hyperreflective foci (HF) in the OCT and higher average level of aqueous IL-1β at baseline (pConclusionsHigher number of HF in the OCT at the initial visit was associated with poor responses to IVBs and an additional dexamethasone implant.
- Published
- 2019